Skincare manufacturing: preservation, stability and the scale-up that ruins a bench formula

A beaker and a jacketed vessel are not the same process

Emulsion structure depends on how energy is applied and how quickly the batch cools, and none of those variables scale linearly. A homogeniser in a production vessel imparts different shear than a laboratory mixer, cooling through a jacket takes far longer than cooling a small beaker, and hold times at temperature change how actives behave. The result is a scale-up that must be treated as development work, ideally through an intermediate pilot batch, rather than as a straight multiplication of the recipe. Brands that skip the pilot step commonly find their first production batch has a different texture from the sample the founder approved.

Preservation is a system, tested against a challenge

Water-containing products support microbial growth, and preservation depends on the whole formulation and its packaging rather than on a single ingredient. Efficacy is demonstrated by deliberately challenging the product with organisms and showing that the system controls them across the shelf life, and that testing takes weeks that cannot be compressed. Consumer pressure towards particular preservative choices has made this harder, since alternatives often work over narrower pH ranges or require higher use levels. Packaging matters too: a jar the user dips fingers into presents a different problem from an airless dispenser.

The actives that sell are usually the ones that degrade

Ascorbic acid oxidises, retinoids are sensitive to light and oxygen, and many acids only perform within a narrow pH window that other ingredients disturb. Formulating around this involves stabilising derivatives, oxygen-excluding packaging, opaque components, and sometimes cold storage of bulk before filling. Every one of those choices raises cost and constrains the packaging conversation that marketing has usually already had. Stability testing under accelerated and real-time conditions is what settles whether a formulation survives its intended life, and it is the step most often shortened when a launch date slips.

Claims must be purchased before they can be printed

Statements about what a product does need supporting evidence proportionate to the claim, which in practice means instrumental measurements, panel studies or consumer perception testing conducted by specialist laboratories. Those studies have to be commissioned early because they run on their own timetable and because their results influence artwork. Brands that write the pack copy first and seek substantiation afterwards either delay the launch or ship a claim they cannot defend when a retailer or regulator asks. Test design also matters, since a study measuring the wrong endpoint supports nothing useful.

Batch size, shelf life and the growth trap

Minimum batch sizes are set by vessel geometry, because a vessel filled too lightly will not mix correctly, and by component supplier minimums. For an early-stage brand that often means producing far more than the first year's demand, with product aging on a shelf life clock. Growing brands then face the opposite problem: the small filler that supported them cannot handle volume, and moving to a larger manufacturer means requalifying the formula, retesting stability and often reformulating around different equipment. Planning the second manufacturer before it is urgent avoids a stock-out during the growth phase.

Frequently asked questions

Why does the first production batch look different from the approved lab sample?

Because the process changed even though the recipe did not. Mixing energy, heating and cooling profiles, hold times and the order of addition all differ at scale, and emulsions are sensitive to every one of them. Colour, viscosity and skin feel can shift noticeably. The fix is a pilot batch on equipment representative of production, with the brand approving that batch rather than the bench sample, and with the process recorded in enough detail to be repeatable.

How long does a new skincare product realistically take?

The formula itself may be settled quickly, but the supporting work is not. Preservative efficacy testing, stability under accelerated and real-time conditions, packaging compatibility, the safety assessment and any claim substantiation each run on their own schedule and partly in sequence. Component tooling and decoration add further time. Brands that plan a launch around formula approval alone are usually surprised; those that map the testing and component chain from the start rarely are.

Why do established brands keep a second manufacturer for the same product?

For supply security and negotiating position. A single filler with a single vessel represents a concentrated risk: equipment failure, a quality issue, capacity given to a larger customer, or a commercial dispute can stop supply entirely. Qualifying a second site costs money and requires repeating stability and compatibility work on batches made there, so it is done selectively for the products that carry the business. The insurance is only real if the second site is exercised periodically.